Tai YT, But PP, Young K, et al. Cardiotoxicity after accidental herb-induced aconite poisoning. Lancet 1992;340:1254-6. View abstract.

Yeih DF, Chiang FT, Huang SKS. Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart 2000;84:E8. View abstract.

But PP, Tai YT, Young K. Three fatal cases of herbal aconite poisoning. Vet Hum Toxicol 1994;36:212-5. View abstract.

Lin CC, Chan TY, Deng JF. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med 2004;43:574-9. View abstract.

Tsukiyama M, Ueki T, Yasuda Y, et al. Beta2-adrenoceptor-mediated tracheal relaxation induced by higenamine from Nandina domestica Thunberg. Planta Med 2009;75:1393-9. View abstract.

Kosuge T, Yokota M, Nagasawa M. Studies on cardiac principle in aconite roots. 1. Isolation and structural determination of higenamine. J Pharm Soc Jap 1978;98:1370-5. View abstract.

Wagner H, Reiter M, Ferstl W. New drugs with cardiotonic activity. Part 1. Chemistry and pharmacology of the cardiotonic active principle of Annona squamosa L. Planta Med 1980;40:77-85. View abstract.

Bao YX, Yu GR, Xu JM, et al. Effect of acute higenamine administration on bradyarrhythmias and HIS bundle. A clinical study of 14 cases and animal experiment on dogs. Chin Med J 1982;95:781-4. View abstract.

Park CW, Chang KC, Lim JK. Effects of higenamine on isolated heart adrenoceptor of rabbit. Arch Int Pharmacodyn Ther 1984;267:279-88. View abstract.

Huang XN, Shi JS, Lu WQ, Liu GX. Antiasthmatic effect of higenamine. Chin Pharm Bull 1985;20:462-4.

Liu WH, Zhou YP, Zeng GY. Effects of dl-demethylcoclaurine on experimental heart failure. Acta Pharm Sinica 1988;23:81-5. View abstract.

Kang YJ, Lee YS, Lee GW, et al. Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root. J Pharmacol Exp Ther 1999;291:314-20. View abstract.

Yun-Choi HS, Pyo MK, Park KM, et al. Anti-thrombotic effects of higenamine. Planta Med 2001;67:619-22. View abstract.

Zhang Z, Liu X, Tao Z, et al. Effects of higeramine on hemodynamics and its tolerability and safety, an experimental study. Zhonghua Yi Xue Za Zhi 2002;82:352-5. View abstract.

Bai G, Yang Y, Shi Q, et al. Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist1. Acta Pharmacol Sin 2008;29:1187-94. View abstract.

Kam SC, Do JM, Choi JH, et al. The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum. Int J Impot Res 2012;24:77-83. View abstract.

Feng S, Hu P, Jiang J. Determination of higenamine in human plasma and urine using liquid chromatography coupled to positive electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:763-8. View abstract.

Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. View abstract.

Grucza K, Kwiatkowska D, Kowalczyk K, Wicka M, Szutowski M, Cholbinski P. Analysis for higenamine in urine by means of UHPLC/MS/MS: Interpretation of results. Drug Test Anal. 2017. View abstract.

Jeter J, DeZee KJ, Kennedy L. A Case of Paraspinal Muscle Rhabdomyolysis in a 22-Year-Old Male After Ingesting a Supplement Containing Higenamine. Mil Med. 2015;180(7):e847-9. View abstract.

Zhang N, Lian Z, Peng X, Li Z, Zhu H. Applications of Higenamine in pharmacology and medicine. J Ethnopharmacol. 2017;196:242-252. View abstract.

Cohen PA, Travis JC, Keizers PHJ, Boyer FE, Venhuis BJ. The stimulant higenamine in weight loss and sports supplements. Clin Toxicol (Phila). 2018:1-6. View abstract.

Wang Y, Geng J, Jiang M, Li C, Han Y, Jiang J. The cardiac electrophysiology effects of higenamine in guinea pig heart. Biomed Pharmacother 2019;109:2348-56. View abstract.

Yan K, Wang X, Wang Z, et al. The risk of higenamine adverse analytical findings following oral administration of plumula nelumbinis capsules. Drug Test Anal 2019;11(11-12):1731-6. View abstract.

Prohibited List. World Anti-Doping Agency. January 2020. Available at: https://www.wada-ama.org/sites/default/files/wada_2020_english_prohibited_list_0.pdf.

Dietary Supplement Ingredient Advisory List. U.S. Food & Drug Administration. Available at: https://www.fda.gov/food/dietary-supplement-products-ingredients/dietary-supplement-ingredient-advisory-list. Updated October 29, 2021. Accessed March 5, 2022.